Progenitor cell therapy, including but not limited to skeletal myoblasts or hematopoietic cells, is considered investigational as a treatment of damaged myocardium.Infusion of growth factors (ie, granulocyte colony stimulating factor) is considered investigational as a technique to increase the numbers of circulating hematopoietic cells as treatment of damaged myocardium.
Localización de Nuestra Oficina principal:
1441 F.D. Roosevelt Ave.
San Juan, P.R. 00936
P.O. Box 363628
San Juan, P.R. 00936-3628